A basic research study showed that TrkB/C activation leads to subsequent activation of MEK/ERK signaling pathway, promoting the activation of ADAM8 mediated by HOXC6 and inducing the metastasis of colon cancer cells that are resistant to chemotherapy. Here, NTRK2 is linked to colonic neoplasm.